Cargando…

Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors

[Image: see text] Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein–ligand recognition and improving...

Descripción completa

Detalles Bibliográficos
Autores principales: Burastero, Osvaldo, Defelipe, Lucas A., Gola, Gabriel, Tateosian, Nancy L., Lopez, Elias D., Martinena, Camila Belen, Arcon, Juan Pablo, Traian, Martín Dodes, Wetzler, Diana E., Bento, Isabel, Barril, Xavier, Ramirez, Javier, Marti, Marcelo A., Garcia-Alai, Maria M., Turjanski, Adrián G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344462/
https://www.ncbi.nlm.nih.gov/pubmed/35737472
http://dx.doi.org/10.1021/acs.jmedchem.1c02012
_version_ 1784761225743171584
author Burastero, Osvaldo
Defelipe, Lucas A.
Gola, Gabriel
Tateosian, Nancy L.
Lopez, Elias D.
Martinena, Camila Belen
Arcon, Juan Pablo
Traian, Martín Dodes
Wetzler, Diana E.
Bento, Isabel
Barril, Xavier
Ramirez, Javier
Marti, Marcelo A.
Garcia-Alai, Maria M.
Turjanski, Adrián G.
author_facet Burastero, Osvaldo
Defelipe, Lucas A.
Gola, Gabriel
Tateosian, Nancy L.
Lopez, Elias D.
Martinena, Camila Belen
Arcon, Juan Pablo
Traian, Martín Dodes
Wetzler, Diana E.
Bento, Isabel
Barril, Xavier
Ramirez, Javier
Marti, Marcelo A.
Garcia-Alai, Maria M.
Turjanski, Adrián G.
author_sort Burastero, Osvaldo
collection PubMed
description [Image: see text] Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein–ligand recognition and improving molecular docking predictions. In this work, we used ethanol as a cosolvent to find relevant interactions for ligands toward protein kinase G, an essential protein of Mycobacterium tuberculosis (Mtb). We validated the hot spots by screening a database of fragment-like compounds and another one of known kinase inhibitors. Next, we performed a pharmacophore-guided docking simulation and found three low micromolar inhibitors, including one with a novel chemical scaffold that we expanded to four derivative compounds. Binding affinities were characterized by intrinsic fluorescence quenching assays, isothermal titration calorimetry, and the analysis of melting curves. The predicted binding mode was confirmed by X-ray crystallography. Finally, the compounds significantly inhibited the viability of Mtb in infected THP-1 macrophages.
format Online
Article
Text
id pubmed-9344462
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-93444622022-08-03 Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors Burastero, Osvaldo Defelipe, Lucas A. Gola, Gabriel Tateosian, Nancy L. Lopez, Elias D. Martinena, Camila Belen Arcon, Juan Pablo Traian, Martín Dodes Wetzler, Diana E. Bento, Isabel Barril, Xavier Ramirez, Javier Marti, Marcelo A. Garcia-Alai, Maria M. Turjanski, Adrián G. J Med Chem [Image: see text] Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein–ligand recognition and improving molecular docking predictions. In this work, we used ethanol as a cosolvent to find relevant interactions for ligands toward protein kinase G, an essential protein of Mycobacterium tuberculosis (Mtb). We validated the hot spots by screening a database of fragment-like compounds and another one of known kinase inhibitors. Next, we performed a pharmacophore-guided docking simulation and found three low micromolar inhibitors, including one with a novel chemical scaffold that we expanded to four derivative compounds. Binding affinities were characterized by intrinsic fluorescence quenching assays, isothermal titration calorimetry, and the analysis of melting curves. The predicted binding mode was confirmed by X-ray crystallography. Finally, the compounds significantly inhibited the viability of Mtb in infected THP-1 macrophages. American Chemical Society 2022-06-23 2022-07-28 /pmc/articles/PMC9344462/ /pubmed/35737472 http://dx.doi.org/10.1021/acs.jmedchem.1c02012 Text en © 2022 American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Burastero, Osvaldo
Defelipe, Lucas A.
Gola, Gabriel
Tateosian, Nancy L.
Lopez, Elias D.
Martinena, Camila Belen
Arcon, Juan Pablo
Traian, Martín Dodes
Wetzler, Diana E.
Bento, Isabel
Barril, Xavier
Ramirez, Javier
Marti, Marcelo A.
Garcia-Alai, Maria M.
Turjanski, Adrián G.
Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
title Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
title_full Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
title_fullStr Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
title_full_unstemmed Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
title_short Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
title_sort cosolvent sites-based discovery of mycobacterium tuberculosis protein kinase g inhibitors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344462/
https://www.ncbi.nlm.nih.gov/pubmed/35737472
http://dx.doi.org/10.1021/acs.jmedchem.1c02012
work_keys_str_mv AT burasteroosvaldo cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT defelipelucasa cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT golagabriel cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT tateosiannancyl cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT lopezeliasd cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT martinenacamilabelen cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT arconjuanpablo cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT traianmartindodes cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT wetzlerdianae cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT bentoisabel cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT barrilxavier cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT ramirezjavier cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT martimarceloa cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT garciaalaimariam cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors
AT turjanskiadriang cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors